Virus News and Research

Latest Virus News and Research

COVID's latest twist: New XBB variant gains strength through recombination, outsmarting immunity and amplifying fusogenicity

Research discusses the emergence of a highly diversified SARS-CoV-2 Omicron subvariant called XBB, which is spreading rapidly around the world. XBB emerged through the recombination of two cocirculating BA.2 lineages, BJ.1 and BM.1.1.1, during the summer of 2022.

18 May 2023

Emergence of sexual-kissing behavior in Mesopotamia and its role in spread of diseases

In a Perspective, Troels Arbøll and Sophie Rasmussen review the ancient history of kissing, particularly the emergence of romantic-sexual kissing in Mesopotamia more than 4000 years ago and its role in the evolution and spread of orally transmitted diseases like herpes simplex virus 1 (HSV-1).

18 May 2023

Investigating the changes in severity and epidemiology of respiratory syncytial virus infections among children

Shifting Epidemiology and Severity of Respiratory Syncytial Virus in Children During the COVID-19 Pandemic.

18 May 2023

Researchers find that SARS-CoV-2 directly infects hepatocytes that cause hyperglycemia

Researchers investigate whether severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused hyperglycemia.

18 May 2023

A covid test Medicare scam may be a trial run for further fraud

Medicare coverage for at-home covid-19 tests ended last week, but the scams spawned by the temporary pandemic benefit could have lingering consequences for seniors.

18 May 2023

Heart transplant patients receiving COVID-19 positive donor hearts may face increased mortality risk

Heart transplant recipients receiving organs from active COVID-19 positive donors may have an increased risk of death at six months and one year when compared to those receiving organs from recently recovered COVID-19 patients and COVID-19 negative patients, according to a study published today in the Journal of the American College of Cardiology.

18 May 2023

UK’s first Centre for Phage Research highlights Actiphage in the KTN UK Phage Innovation Showcase

Tuberculosis is caused by a bacterium that has evolved to evade the body’s immune system; now, its natural enemy, a phage, is being used to detect the infection at an early stage.

18 May 2023

Post-COVID condition varies by variant and vaccination status

Research investigates the post-COVID-19 condition, analyzing its profiles based on viral variants and vaccination status. Understanding these profiles can aid in personalized patient care.

17 May 2023

Novel antibodies target human receptors to neutralize SARS-CoV-2 variants and future sarbecoviruses

Researchers generated six human monoclonal antibodies that prevented infection.

17 May 2023

Are masks effective in the protection against COVID-19?

Researchers discussed the efficacy of masks in preventing coronavirus disease 2019 (COVID-19).

17 May 2023

Nemours Children's Health selected to conduct first gene therapy clinical trial for Morquio A syndrome

As part of the Foundation for the National Institutes of Health Accelerating Medicines Partnership Bespoke Gene Therapy Consortium, Nemours Children's Health has been chosen to conduct a first-of-its-kind gene therapy clinical trial for Morquio A syndrome.

16 May 2023

Cancer patients can initiate SARS-CoV-2 vaccination three months after bone marrow transplant

Patients with cancer whose immune systems are being supported or rebuilt by bone marrow transplantation should begin receiving vaccines for protection against SARS-CoV-2 three months post-transplant, according to a large, prospective, observational study led collaboratively by the Center for International Blood and Marrow Transplant Research, the Blood & Marrow Transplant Clinical Trials Network and Fred Hutchinson Cancer Center.

16 May 2023

Study identifies two novel highly pathogenic avian influenza viruses (H5N1) clade 2.3.4.4b.2

Researchers investigated the genetic origin, distribution patterns, and antigenicity of novel AIVs.

16 May 2023

The discovery of a novel orthonairovirus from Dermacentor silvarum ticks near the China–North Korea border

Researchers isolated a novel virus of the Orthonairovirus genus.

16 May 2023

Novel 'CLEVER' method accelerates engineering and genetic study of SARS-CoV-2 and its variants

Researchers described rapid mutagenesis and rescue of SARS-CoV-2 variants without cloning.

16 May 2023

Insights from blood donors: Serosurveillance reveals population insights for targeted health interventions

Research highlights the effectiveness of serosurveillance in monitoring SARS-CoV-2 exposure within a population. It emphasizes the importance of considering demographic variations in antibody prevalence to inform targeted public health strategies.

16 May 2023

Clinical trial of a combination treatment shows great promise for patients with glioblastoma

A new international study published in Nature Medicine and presented as a late-breaking abstract at the American Association of Neurological Surgeons annual conference, shows great promise for patients with glioblastoma.

15 May 2023

Phase 1 trial of experimental universal influenza vaccine begins enrolling volunteers

A clinical trial of an experimental universal influenza vaccine developed by researchers at the National Institute of Allergy and Infectious Diseases' (NIAID) Vaccine Research Center (VRC), part of the National Institutes of Health, has begun enrolling volunteers at Duke University in Durham, North Carolina.

15 May 2023

Combination approach is safe, improves survival outcomes in a subset of glioblastoma patients

Intratumoral delivery of an engineered oncolytic virus (DNX-2401) targeting glioblastoma (GBM) cells combined with subsequent immunotherapy was safe and improved survival outcomes in a subset of patients with recurrent GBM, according to results from a multi-institutional Phase I/II clinical trial co-led by researchers at The University of Texas MD Anderson Cancer Center and the University of Toronto.

15 May 2023

Alcohol-based disinfectants can effectively protect against monkeypox viruses

The virus remains infectious on steel surfaces for up to 30 days, but can be effectively inactivated by alcohol-based disinfectants.

15 May 2023

Previous
1
...
94
95
96
97
98
99
100
...
1542
Next

Virus News and Research

Latest Virus News and Research

COVID's latest twist: New XBB variant gains strength through recombination, outsmarting immunity and amplifying fusogenicity

Emergence of sexual-kissing behavior in Mesopotamia and its role in spread of diseases

Investigating the changes in severity and epidemiology of respiratory syncytial virus infections among children

Researchers find that SARS-CoV-2 directly infects hepatocytes that cause hyperglycemia

A covid test Medicare scam may be a trial run for further fraud

Heart transplant patients receiving COVID-19 positive donor hearts may face increased mortality risk

UK’s first Centre for Phage Research highlights Actiphage in the KTN UK Phage Innovation Showcase

Post-COVID condition varies by variant and vaccination status

Novel antibodies target human receptors to neutralize SARS-CoV-2 variants and future sarbecoviruses

Are masks effective in the protection against COVID-19?

Nemours Children's Health selected to conduct first gene therapy clinical trial for Morquio A syndrome

Cancer patients can initiate SARS-CoV-2 vaccination three months after bone marrow transplant

Study identifies two novel highly pathogenic avian influenza viruses (H5N1) clade 2.3.4.4b.2

The discovery of a novel orthonairovirus from Dermacentor silvarum ticks near the China–North Korea border

Novel 'CLEVER' method accelerates engineering and genetic study of SARS-CoV-2 and its variants

Insights from blood donors: Serosurveillance reveals population insights for targeted health interventions

Clinical trial of a combination treatment shows great promise for patients with glioblastoma

Phase 1 trial of experimental universal influenza vaccine begins enrolling volunteers

Combination approach is safe, improves survival outcomes in a subset of glioblastoma patients

Alcohol-based disinfectants can effectively protect against monkeypox viruses

A new way of characterising biomolecules eBook

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in